August 11, 2020 Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes , September 2019
June 19, 2020 Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis
June 14, 2020 Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington’s Disease
May 14, 2020 Serum Glutamate Dehydrogenase Activity Enables Early Detection of Liver Injury in Subjects with Underlying Muscle Impairments
April 21, 2020 Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: the 2019 Expert Consensus From the Transplant Society Working Group
February 24, 2020 Use of Biomarkers to Improve Immunosuppressive Drug Development and Outcomes in Renal Organ Transplantation: A Meeting Report
December 5, 2019 Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson’s Disease to Inform Clinical Trial Designs Ahamadi M, Conrado DJ, Macha S, Sinha V, Stone J, Burton J, Nicholas T, Gallagher J, Dexter D, Bani M, Boroojerdi B, Smit...
October 22, 2019 Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
October 9, 2019 On September 25th, the FDA published a Personal Viewpoint in the American Journal of Transplantation
